Sigilon Therapeutics Inc.

NASDAQ: SGTX · Real-Time Price · USD
22.47
-0.59 (-2.56%)
At close: Aug 10, 2023, 10:00 PM

Sigilon Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
42.07M 107.14M
Short-Term Investments
27.56M 16.21M
Long-Term Investments
n/a n/a
Other Long-Term Assets
1.03M 1.12M
Receivables
3.46M 59K
Inventory
250K 250K
Other Current Assets
1.08M 2.73M
Total Current Assets
74.41M 126.39M
Property-Plant & Equipment
11.83M 16.86M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
12.87M 17.98M
Total Assets
87.28M 144.37M
Account Payables
936K 2.34M
Deferred Revenue
12.88M 17.03M
Short-Term Debt
11.15M 6.51M
Other Current Liabilities
6.02M 9M
Total Current Liabilities
30.99M 34.89M
Long-Term Debt
16.91M 26.99M
Other Long-Term Liabilities
233K n/a
Total Long-Term Liabilities
17.14M 32.32M
Total Liabilities
48.14M 67.21M
Total Debt
28.06M 33.5M
Common Stock
32K 32K
Retained Earnings
-256.8M -213.24M
Comprehensive Income
-429K -10K
Shareholders Equity
39.14M 77.16M
Total Investments
27.56M 16.21M